Acorda Therapeutics Inc (ACORQ)
0.879
+0.08
(+9.88%)
USD |
OTCM |
May 07, 15:23
Acorda Therapeutics Total Long Term Debt (Quarterly): 186.14M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 186.14M |
September 30, 2023 | 181.04M |
June 30, 2023 | 176.16M |
March 31, 2023 | 171.50M |
December 31, 2022 | 167.03M |
September 30, 2022 | 187.69M |
June 30, 2022 | 184.98M |
March 31, 2022 | 182.44M |
December 31, 2021 | 178.67M |
September 30, 2021 | 175.38M |
June 30, 2021 | 172.33M |
March 31, 2021 | 236.90M |
December 31, 2020 | 234.80M |
September 30, 2020 | 229.65M |
June 30, 2020 | 224.77M |
March 31, 2020 | 220.65M |
December 31, 2019 | 218.87M |
September 30, 2019 | 351.49M |
June 30, 2019 | 349.63M |
March 31, 2019 | 346.46M |
December 31, 2018 | 343.76M |
September 30, 2018 | 341.46M |
June 30, 2018 | 339.01M |
March 31, 2018 | 337.79M |
December 31, 2017 | 335.12M |
Date | Value |
---|---|
September 30, 2017 | 332.22M |
June 30, 2017 | 328.71M |
March 31, 2017 | 327.12M |
December 31, 2016 | 331.05M |
September 30, 2016 | 298.24M |
June 30, 2016 | 295.98M |
March 31, 2016 | 293.74M |
December 31, 2015 | 292.70M |
September 30, 2015 | 295.73M |
June 30, 2015 | 293.76M |
March 31, 2015 | 291.81M |
December 31, 2014 | 291.03M |
September 30, 2014 | 289.13M |
June 30, 2014 | 287.23M |
March 31, 2014 | 3.255M |
December 31, 2013 | 4.372M |
September 30, 2013 | 4.34M |
June 30, 2013 | 4.309M |
March 31, 2013 | 4.277M |
December 31, 2012 | 5.388M |
September 30, 2012 | 5.903M |
June 30, 2012 | 5.82M |
March 31, 2012 | 5.765M |
December 31, 2011 | 6.374M |
September 30, 2011 | 7.784M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
167.03M
Minimum
Dec 2022
351.49M
Maximum
Sep 2019
212.11M
Average
186.14M
Median
Dec 2023
Total Long Term Debt (Quarterly) Benchmarks
BioSig Technologies Inc | 0.00 |
Verve Therapeutics Inc | 0.00 |
Spectral AI Inc | 0.632M |
AIM ImmunoTech Inc | 0.00 |
Protalix BioTherapeutics Inc | 20.25M |